Current Activities

GaBI Journal

The mission of GaBI Journal (official Journal of the Generics and Biosimilars Initiative) is to provide an independent, high quality, authoritative, and peer reviewed platform for the publication of scientific articles concerning any aspect of the research into and development of cost-effective medicines, irrespective of their source.

GaBI Journal strives to satisfy the needs of a wide readership, offering high quality relevant reports, studies, analyses and updates on issues of interest to healthcare practitioners, policymakers and drug developers.

GaBI Journal – print ISSN: 2033-6403; online ISSN: 2033-6772

GaBI Journal Educational Series

Biosimilars for Healthcare Professionals
Biosimilarity and Interchangeability
Generic Immunosuppressants in Transplantation
Non-Biological Complex Drugs
INN for biosimilars

GaBI Online

GaBI Online aims to be a one-stop portal containing news, a repository of worldwide guidelines and an archive of related scientific information. It seeks to provide readers with the latest updates on developments in generic and biosimilar medicines, and to serve as a communication vehicle to reach key members of the healthcare world.

GaBI Online subscribers can stay informed by receiving weekly online alerts on the latest news on generic and biosimilar medicines from different perspectives covering information on research and general news, policies and legislation, worldwide guidelines, scientific and interview reports, news and reports of major conferences and events.

LATIN AMERICAN FORUM

The new section of the ‘Latin American Forum’ on GaBI has been launched.  The objective of this new section is to provide you with all the latest news and updates on developments of generic and biosimilar medicines in Latin America in Spanish.

Browse the news in the Latin American Forum!

Register to receive the GaBI Latin American Forum newsletter. Inform colleagues and friends of this new initiative.

FORO LATINOAMERICANO

Se ha lanzado la nueva sección del ‘Foro Latinoamericano’ sobre GaBI. El objetivo de esta nueva sección es brindarle las últimas noticias y actualizaciones sobre desarrollos de medicamentos genéricos y biosimilares en América Latina en español.

¡Explore las noticias en el Foro Latinoamericano!

Regístrese para recibir el boletín informativo GaBI Foro Latinoamericano. Informe a colegas y amigos sobre esta nueva iniciativa.

Source URL: https://gabi-journal.net/about-gabi/current-activities


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048